Ładuje się......
What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance
Defibrotide (DF) has received European Medicines Agency authorization to treat sinusoidal obstruction syndrome, an early complication after hematopoietic cell transplantation. DF has a recognized role as an endothelial protective agent, although its precise mechanism of action remains to be elucidat...
Zapisane w:
| Wydane w: | Blood |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society of Hematology
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817313/ https://ncbi.nlm.nih.gov/pubmed/26755708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-10-676114 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|